AGP Executive Report

Regulatory Backlash: A Fox News segment spotlights California’s “killjoy” bureaucracy and legal fight over AB 2624, framing it as a growing headache for entrepreneurs and freedom-minded operators. Workplace & Safety: A business-focused piece argues workplace cannabis testing is getting harder to interpret as medical cannabis access expands, warning employers against “drug thinking” that treats one result as one meaning. Medical Cannabis in the Real World: A study roundup says cancer patients report symptom improvement with medical cannabis, adding to the growing clinical conversation around symptom relief. Community CBD Culture: Gisborne’s Māori Language Week drew dozens for CBD karakia sessions, mixing community tradition with wellness culture. Industry Moves (ASX): Botanix Pharmaceuticals updates investors on patent progress (drug substance, applicator, and European coverage) while Cann Group secures a Mildura GMP licence; Emyria reports expanding psychedelic-assisted therapy clinic revenue and coverage. Local Cannabis Access: Dixon, Illinois clears the way for a cannabis drive-thru after state law changes. Enforcement Watch: Nigeria’s NDLEA reports synthetic cannabis (“Colorado/Colos”) seizures from UK shipments and arrests tied to cargoes hidden in speakers.

Medical Cannabis Research: A Minnesota study of 6,621 cancer patients in the state’s program found self-reported symptom improvements after enrollment, including nausea, vomiting, appetite loss, anxiety, depression and pain. Product Safety & Regulation: Ohio’s Vext Sciences dispensary Herbal Wellness Center voluntarily closed after two customers reported serious adverse health effects following use of a vape pen; the company says it has no substantiated link yet and placed certain products on precautionary hold pending lab review. CBD/Topicals Consumer Angle: A UK wellness brand is promoting a fragrance-free CBD balm (800mg CBD plus CBG) for aches and pains, claiming fast local relief and offering a limited discount. Policy & Access (US): Illinois expanded medical cannabis access as more dispensaries and licenses roll out, while Kansas election debates spotlighted cannabis legalization and Medicaid expansion. Enforcement (Nigeria): NDLEA reported major synthetic cannabis (“Colorado/Colos”) seizures from UK-linked shipments and arrests, underscoring ongoing trafficking pressure around cannabis-related drugs. Public Health Warning: “Medfluencers” and AI health personalities are being criticized for pushing unproven, potentially dangerous “miracle cures,” including misleading supplement and drug claims.

Medical Cannabis Outcomes: Minnesota’s Office of Cannabis Management study reports cancer patients in the state program saw symptom improvements, including nausea, vomiting, and appetite loss, based on self-ratings from 6,621 patients (2015–2023). Product & Safety Focus: A comparison roundup highlights how “high-potency” CBD topicals vary widely by mg claims, format, cannabinoid mix, and testing—useful for shoppers trying to pick the right cream or balm. Regulatory & Market Moves: Missouri hemp-THC beverage makers are preparing for a looming federal ban (delayed to Dec. 11), with some firms pivoting back toward CBD-style products. Local Cannabis Expansion: Olmsted County, Minnesota, still has more than a dozen licensed cannabis retailers/dispensaries not yet open a year after lotteries, with several in construction or planning. Community & Youth Concerns: An Illinois community forum (“It’s Not Just Weed”) brought parents together to push back on THC products reaching teens, echoing broader worries about concentrated cannabis. Enforcement & Illicit Supply: Bulgaria’s anti-drug crackdown included online sales, large vape seizures, and investigations tied to synthetic cannabinoids and related distribution.

Kansas State Fair Debate: Kansas governor candidates Ty Masterson and Cindy Holscher clashed over affordability, Medicaid, and cannabis, with Holscher pushing legalization and Masterson attacking her record. Missouri Hemp THC Shake-Up: Missouri hemp-THC beverage makers brace for a federal ban delayed to Dec. 11, with some planning to pivot back toward CBD products. Local Cannabis Delays: In Olmsted County, Minnesota, more than a year after licensing, most recreational cannabis retailers still haven’t opened, citing construction and build-out hurdles. Youth THC Warning: Illinois parents and experts urged against teen use of highly concentrated THC products after concerns about access and rising ER worries. Product Focus: A roundup compares high-potency CBD topicals, highlighting that mg labels don’t tell the whole story without ingredients and testing. Medical Cannabis Growth: Norridgewock, Maine approved converting a former chicken barn into a medical marijuana grow site, setting conditions for permits. International Enforcement: Sri Lanka police uncovered an illegal hashish and marijuana cultivation attempt, signaling a shift toward local production. CBD Safety/Use in Real Life: A Santa Maria DUI checkpoint notice explicitly flags cannabis impairment as illegal and urges sober driving plans.

Regulatory Drafting: Virginia Cannabis Control Authority released an 82-page draft for its 2027 adult-use retail marijuana market, with final rules expected in December, as prospective licensees push for clearer timelines before investing. Medical Outcomes: Minnesota’s medical cannabis program study (6,621 cancer patients) reports symptom relief within four months for nausea, vomiting, and appetite loss, plus improvements for anxiety and depression. Court Watch: Nebraska’s Supreme Court rejected a challenge to the state’s voter-approved medical cannabis law, saying the opponent lacked standing, while the state also finalized its fall 2026 ballot after a lawsuit-heavy process. Public Safety & Compliance: Santa Maria, California announced a DUI checkpoint that will treat cannabis like other impairing substances, and SUNY Oswego launched a new Cannabis Studies minor covering science, law, business, and wellbeing. Industry Expansion: Cilo Cybin is ramping up extraction and adding an edibles production line expected to come online in 2027, aiming to expand beyond oils and vapes. Consumer Safety: Texas authorities reported multiple students hospitalized after eating THC gummies at school, with the investigation focused on how the gummies were obtained.

Metabolic Research: A new mouse study suggests whole-plant cannabis extract improves glucose control more than THC alone, pointing to non-THC plant compounds and warning it’s preclinical. Cancer Symptom Relief: Minnesota’s medical cannabis program study reports improvements for cancer patients’ nausea, vomiting, appetite loss, plus anxiety and depression within months. Regulatory/Legal Watch: Mexico’s Supreme Court says authorized adults can cook cannabis into prepared foods for personal use under a permit, without creating a commercial edible market. State Policy Moves: Illinois authorized 37 existing dispensaries to sell medical cannabis products to patients while also serving adult-use customers at the same locations. Courtroom Setback: Nebraska’s Supreme Court rejected another challenge to voter-approved medical cannabis laws, dismissing a case for lack of standing. Public Health Alert: New York plans to crack down on unlicensed cannabis drinks sold in grocery stores, calling the “black market” a public-health risk. Safety Incident: Five San Antonio middle school students were hospitalized after eating THC gummies brought to campus, expected to recover.

Regulation Update (UK): England and Wales’ Food Standards Agency says it will recommend government approval for market authorisation of CBD cannabis-derived food supplements, moving ~3,000 products closer to staying on shelves under the “novel food” framework. Travel Warning (US): The U.S. State Department reiterates that Americans can face local criminal penalties for carrying marijuana or CBD/THC products abroad, even if legal at home. Data Security (ID checks): IDScan confirmed hackers accessed data tied to a reported 153 million driver’s license scans, raising concerns for customers including cannabis dispensary clients. Public Health (Cannabis policy): A systematic review links cannabis legalization to higher young-adult cannabis use and, in some studies, more emergency visits/poison reports. Medical Cannabis Access (Illinois): Illinois regulators allow adult-use dispensaries to opt into medical sales at the same location, expanding patient access. Safety & Youth (Texas): Five students were hospitalized after allegedly eating THC gummies at school; officials expect recovery.

Illinois Medical Access Expansion: Illinois regulators issued medical cannabis dispensary licenses to 37 existing adult-use shops, letting them sell to registered patients at the medical tax rate and boosting access while cutting red tape. CBD for Health & Recovery: A new scientific review says CBD may help with delayed-onset muscle soreness and reduce muscle-damage markers after hard workouts, but it doesn’t directly boost performance—and mislabeled products could risk accidental THC exposure. Seizure-Disorder Outcomes: New data from Minnesota patients found 68% reported fewer seizures after using state-authorized medical cannabis products, with dry mouth and fatigue among the most common side effects. Lower Urinary Tract Relief: A Canadian scoping review reports cannabis preparations were linked to symptom improvements for incontinence and other LUTS, especially in multiple sclerosis patients. Public Safety & Enforcement: Baltimore’s City Council advanced a bill to let police “padlock” smoke shops with repeated documented violations of selling unlicensed cannabis or controlled substances. Legal/Market Pressure: Michigan faces a supply glut, with nearly 2 million pounds already in the legal chain midyear, adding pressure as growers brace for another outdoor harvest. CBD for Pets: A guide highlights how CBD oil may be used for pet wellness without getting animals “high,” stressing responsible dosing and product choice.

US Travel Warning: The State Department says Americans can still face arrest for carrying marijuana or CBD products across borders, even if they’re legal at home—vapes, oils, edibles, and THC/CBD are all covered. Hemp Ban Delay: A federal funding bill pushes the hemp ban back to December, giving the industry more time to negotiate a new regulatory framework. Medicinal Cannabis Milestone: Massachusetts adult-use cannabis sales topped $10B as regulators prepare for the next phase of licensing and oversight. Regulatory Clampdowns: Norwood, Massachusetts moved to restrict kratom and synthetic cannabinoids, while Islamabad’s court ordered rules for sheesha cafés after concerns about tobacco/cannabis mixing and youth access. Industry Watch (ASX): Little Green Pharma, Botanix, ECS Botanics, and IDT Australia updates keep attention on integration, launch execution, and compliant manufacturing for medicinal cannabis. Patient Access: New Orleans opened its first French Quarter marijuana dispensary with same-day telehealth clinician approvals for medical purchases. Road Safety: A California DUI crackdown reminded drivers that impairment can come from cannabis and other substances, not just alcohol.

Massachusetts Legal Market Milestone: Ten years after voters legalized adult-use cannabis, Massachusetts adult-use retailers crossed $10B in gross sales (Sept. 5), with officials calling it a jobs-and-tax engine while warning the next phase brings new license types and policy fights. Youth THC Safety Push: In Ohio, Hamilton’s push for dispensaries sparked a community event focused on harms from today’s high-potency THC products, featuring a youth prevention group tied to a family tragedy. Georgia Medical Cannabis Rules Clarified: Georgia dispensaries can sell flower, but a new law still bars smoking—patients can only vaporize at home, creating confusion for retailers. CBD Policy Pressure: The U.S. State Department warned Americans not to travel internationally with marijuana or CBD products due to severe local penalties. Hemp Ban Fallout: Kentucky hemp businesses warned a delayed federal hemp ban could be a “first nail in the coffin” for CBD sales. Product Access & Safety: Maine’s Office of Cannabis Policy will continue its Safe Storage for ME program, distributing 12,000 free lockable storage bags. Regulatory Clampdown Abroad: Islamabad imposed a complete ban on shisha cafes after an IHC order, with sealing and cases for violations. Research Watch: A preclinical study reports CBG prevented long-term memory impairment in a schizophrenia-related rat model, pointing to new avenues for cognitive research.

Medical Access Expansion: nuEra Cannabis will expand Illinois medical cannabis service to five more dispensaries starting Sept. 10, giving registered patients more local options and support. Federal Policy Pressure: A new federal law delays major hemp restriction changes until Dec. 11, buying time for a clearer regulatory framework for hemp-derived cannabinoids. DEA/Rescheduling Watch: Industry analysis flags a shift toward greater DEA involvement as marijuana rescheduling moves forward, raising new compliance questions for operators. Regulatory Enforcement: California says its legal cannabis market has generated nearly $8.4B in tax revenue since 2018 while regulators remove thousands of illegal hemp/kratom/7-OH products from shelves. Public Safety & Compliance: Nevada reiterates that public smoking is generally illegal outside approved consumption lounges, even though adult-use cannabis is legal. Market Licensing: Virginia prepares for July 2027 adult-use sales with a lottery to award up to 350 dispensary licenses, with medical operators expected to convert to dual use. Business/Branding: Celebrity-backed functional drinks keep pushing into CBD/cannabinoid beverages, including a CBD-infused line from TRIP.

Federal Hemp Policy: Trump delayed a federal crackdown on hemp-derived THC to Dec. 11, but Texas’ Schedule I-style ban on most hemp THC products still stands, with a judge refusing to block it. State Medical Cannabis Rules: Georgia’s “Putting Patients First” law lets dispensaries sell dry-herb flower, but home use is limited to vaporization—smoking remains illegal, creating confusion for patients. Product & Market Moves: LIX Pet Wellness launched Advanced Formula: Feline, adding CBD/CBG/CBN for cat wellness; Ananda Health acquired Elixinol’s U.S. operations and expanded contract manufacturing/3PL ahead of the Dec. 11 hemp shift. Research Watch: A lab study suggests common vaping additives, including CBD and vitamin E, can soften lung surfactant at high concentrations, raising caution for vapers and parents. Industry/Business: InterCure says it regained Nasdaq minimum bid-price compliance after a delisting notice. Events: Southern Illinois Hemp and Cannabis Symposium returns Sept. 18 with policy, agronomy, and biomedical sessions.

Regulated CBD & cannabis industry: Dunbar Pharma will showcase its EU GMP-certified, plant-derived dronabinol API at expopharm 2026 in Munich, pitching “quality beyond the certificate” and long-term supply continuity for pharmacists. Clinical CBD research: Avecho’s pivotal cannabidiol insomnia trial cleared a key interim review, with an independent monitoring board recommending the study continue at its planned size, while recruitment for the final stage restarts. Company moves in medicinal cannabis: Little Green Pharma completed its Cannatrek merger, expanding cultivation/manufacturing and clinic operations across Australia and Europe, and the market is watching integration and cost synergies. Policy & risk around hemp THC: Texas coverage highlights tighter restrictions on hemp-derived THC products after a Texas Supreme Court ruling, with critics pointing to confusing rules and harsh penalties. Insurance/coverage implications: A separate analysis argues a federal ban on intoxicating hemp products will reshape risk and coverage, citing a new “total THC” approach and low per-container limits that could make most current products federally unlawful. Enforcement pressure: Phuket dispensaries faced permit losses and suspensions after an enforcement drive, with alleged breaches spanning traditional medicine and food regulations. Workforce & safety training: Oklahoma’s cannabis industry is pushing workforce training after a fatal THC extraction facility explosion, with colleges partnering on online safety and compliance courses.

CBD & Alcohol Research: A new review says CBD still hasn’t shown clear effectiveness for alcohol use disorder in human trials, with animal results only “slight” and inconsistent on craving. CBD in Animal Wellness: Votum Labs launched a CBD pet spray (SOS by Happy Pets) aimed at fireworks and travel anxiety, claiming THC is filtered out and calm is promoted without sedation. Regulatory/Legal Watch: A U.S. congressional research report highlights a split in court rulings on whether state marijuana licensing can disadvantage out-of-state operators—raising the odds the Supreme Court may step in. Workplace & Compliance: New Zealand reporting flags workplace drug testing challenges for medicinal cannabis users, underscoring how employers struggle to get policies right. Industry & Security: IDScan.net faces multiple class-action lawsuits after an alleged breach involving tens of millions of driver’s licenses, with links reported to scans at a cannabis dispensary. Local Policy: Perrysburg, Ohio council approved medical marijuana/adult-use cannabis rules with strict zoning and advertising limits, while some members opposed dispensaries.

Harm-Reduction Push in Europe: Switzerland’s pharmacy cannabis pilot (Bern, Biel, Lucerne) says legal access hasn’t increased use and is being folded into federal law updates, with the program extended to 2028. Federal Hemp/Insurance Shockwaves: A U.S. viewpoint warns Congress’s “total THC” rules and the tightening of intoxicating hemp product limits could make most delta-8-style items federally unlawful and reshape risk and coverage. Public Health Alerts: Nova Scotia’s Membertou Health Centre is investigating a report of fentanyl detected in cannabis. Enforcement Crackdown: Nigeria’s NDLEA seized 2,145kg of cannabis from a hidden-compartment fuel tanker and also recovered millions of opioid pills, plus cannabis-infused cookies/gummies. Medical Access Expansion: Trulieve is opening a new medical cannabis dispensary in Dunwoody, Georgia, aiming to expand patient options. Policy Fight in North Carolina: A hemp coalition is pressuring regulators as federal rules stay in flux, with Winston-Salem highlighted as a key battleground. Road Safety Concern: A coroner report in New Zealand links a double-fatal crash to speed/fatigue/distress and meth intoxication, while cannabis is flagged as a serious concern for lawmakers. Community & Education: Ohio is urging back-to-school conversations that include informed cannabis decisions alongside alcohol safety.

Hemp Policy Clash: North Carolina’s hemp-derived THC fight heats up as CBHD pressures Winston-Salem and lawmakers to rethink intoxicating hemp rules amid a federal “extinction event,” with THC thresholds and age limits at the center. Public Health Alert: Nova Scotia’s Membertou Health Centre is investigating a report of fentanyl detected in cannabis, prompting a community drug alert and distribution of testing strips and naloxone. Regulation & Safety: A survey of Auckland pharmacies found 54% of prescriptions had legal/subsidy errors, raising compliance concerns for patients and reimbursement. Medical Cannabis Expansion: Trulieve is opening a new medical cannabis dispensary in Dunwoody, Georgia, adding product formats and patient access. Driving Risk: Authorities in California remind drivers that marijuana impairment is illegal, with Labor Day DUI checkpoints funded via the Cannabis Tax Fund. Legal/Enforcement: NDLEA reports major nationwide drug seizures, including cannabis hidden in a fuel tanker and millions of opioid pills recovered. CBD Consumer Debate: A Texas legal analysis warns delta-8 THC gummies face harsher felony exposure as hemp rules tighten.